These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 10528144)
1. Effects of alniditan on neurogenic oedema in the rat dura mater and on contraction of rat basilar artery. Limmroth V; Bischoff A; Fetscher C; Wermelskirchen D; Diener H; Michel MC Eur J Pharmacol; 1999 Oct; 382(2):103-9. PubMed ID: 10528144 [TBL] [Abstract][Full Text] [Related]
2. 5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endothelium. Bhattacharya A; Schenck KW; Xu YC; Nisenbaum L; Galbreath E; Cohen ML J Pharmacol Exp Ther; 2004 May; 309(2):825-32. PubMed ID: 14724223 [TBL] [Abstract][Full Text] [Related]
4. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan. Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979 [TBL] [Abstract][Full Text] [Related]
5. Selective vasoconstriction by alniditan in the carotid vascular bed of anaesthetized dogs. Van de Water A; D'Aubioul J; Van Gerven W; Van Ammel K; De Clerck F Eur J Pharmacol; 1996 Mar; 299(1-3):127-37. PubMed ID: 8901015 [TBL] [Abstract][Full Text] [Related]
6. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines. Lesage AS; Wouters R; Van Gompel P; Heylen L; Vanhoenacker P; Haegeman G; Luyten WH; Leysen JE Br J Pharmacol; 1998 Apr; 123(8):1655-65. PubMed ID: 9605573 [TBL] [Abstract][Full Text] [Related]
7. The 5-HT1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater. Yu XJ; Cutrer FM; Moskowitz MA; Waeber C Neuropharmacology; 1997 Jan; 36(1):83-91. PubMed ID: 9144644 [TBL] [Abstract][Full Text] [Related]
8. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater. Buzzi MG; Moskowitz MA; Peroutka SJ; Byun B Br J Pharmacol; 1991 Jun; 103(2):1421-8. PubMed ID: 1653072 [TBL] [Abstract][Full Text] [Related]
9. GR127935 is a potent antagonist of the 5-HT1-like receptor mediating contraction in the canine coronary artery. Terrón JA Eur J Pharmacol; 1996 Apr; 300(1-2):109-12. PubMed ID: 8741174 [TBL] [Abstract][Full Text] [Related]
10. Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord. Manuel NA; Wallis DI; Crick H Br J Pharmacol; 1995 Nov; 116(6):2647-54. PubMed ID: 8590984 [TBL] [Abstract][Full Text] [Related]
11. 5-HT(1A) and 5-HT(1B/1D) receptors are involved in the modulation of the trigeminovascular system of the cat: a microiontophoretic study. Boers PM; Donaldson C; Zagami AS; Lambert GA Neuropharmacology; 2000 Jul; 39(10):1833-47. PubMed ID: 10884564 [TBL] [Abstract][Full Text] [Related]
12. Evidence that 5-HT2 receptors predominantly mediate the contraction of the rat basilar artery to 5-hydroxytryptamine. Deckert V; Angus JA Eur J Pharmacol; 1992 Oct; 221(1):17-25. PubMed ID: 1459189 [TBL] [Abstract][Full Text] [Related]
13. Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats. Reuter U; Salomone S; Ickenstein GW; Waeber C Cephalalgia; 2004 May; 24(5):398-407. PubMed ID: 15096229 [TBL] [Abstract][Full Text] [Related]
14. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist. Gupta P; Butler P; Shepperson NB; McHarg A Eur J Pharmacol; 2000 Jun; 398(1):73-81. PubMed ID: 10856450 [TBL] [Abstract][Full Text] [Related]
15. The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation. Gupta P; Brown D; Butler P; Ellis P; Grayson KL; Land GC; Macor JE; Robson SF; Wythes MJ; Shepperson NB Br J Pharmacol; 1995 Nov; 116(5):2385-90. PubMed ID: 8581273 [TBL] [Abstract][Full Text] [Related]
16. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries. Ellwood AJ; Curtis MJ Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503 [TBL] [Abstract][Full Text] [Related]
17. Characterisation of the contractile activity of eletriptan at the canine vascular 5-HT1B receptor. Gupta P; Scatchard J; Napier C; McHarg A; Wallis R Eur J Pharmacol; 1999 Feb; 367(2-3):283-90. PubMed ID: 10079003 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the human basilar artery contractile response to 5-HT and triptans. Silva SA; Marques FB; Fontes Ribeiro CA Fundam Clin Pharmacol; 2007 Jun; 21(3):265-72. PubMed ID: 17521295 [TBL] [Abstract][Full Text] [Related]
19. 2-(2-Aminoethyl)-quinoline (D-1997): a novel agonist at 5-hydroxytryptamine1-like receptors in the canine basilar artery. Terrón JA; López-Muñoz FJ; Hong E; Villalón CM Arch Int Pharmacodyn Ther; 1994; 327(1):56-68. PubMed ID: 7944828 [TBL] [Abstract][Full Text] [Related]
20. Characterization of 5-HT receptors on human pulmonary artery and vein: functional and binding studies. Cortijo J; Martí-Cabrera M; Bernabeu E; Domènech T; Bou J; Fernández AG; Beleta J; Palacios JM; Morcillo EJ Br J Pharmacol; 1997 Dec; 122(7):1455-63. PubMed ID: 9421295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]